Answers are grounded in this paper and cite their sources.
Sleep homeostasis is essential for health, and sleep disturbances contribute to multi-organ failure mortality. Dihydromyricetin (DMY), a flavonoid from Ampelopsis grossedentata, possesses anti-inflammatory and antioxidant activities. Although DMY alleviates sleep-deprivation-induced cognitive deficits, its role in sleep regulation remains unclear. Here, we show that DMY increases sleep duration and modulates sleep fragmentation in young, aged, and short-sleep mutant Drosophila. Transcriptomic and genetic analyses reveal that DMY alters the expression of neurotransmitter-related genes, including VGAT and Trhn, suggesting potential involvement of GABAergic and serotonergic signaling. In paraquat-induced oxidative stress models, DMY boosts antioxidant gene expression, alleviates oxidative damage and intestinal apoptosis, restores stress-disrupted sleep, and extends lifespan. Together, our findings demonstrate that DMY improves sleep-associated parameters, potentially involving neurotransmitter-related signaling pathways while concurrently mitigating oxidative stress-induced damage, thereby promoting organismal health and suggesting its potential for preventing and treating sleep disorders and aging-related decline.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: